Literature DB >> 2372002

Delayed excess mortality after exposure to measles during the first six months of life.

P Aaby1, J Bukh, D Kronborg, I M Lisse, M C da Silva.   

Abstract

In an urban area of Guinea-Bissau, 71 children exposed to measles before age 6 months had a mortality risk of 34% (95% confidence interval (Cl) 24-47) between 6 and 60 months of age. The mortality risk for the 205 other children of the same birth cohort who had not been exposed to or developed measles was 11% (95% Cl 9-15), a significant difference compared with exposed children. With a version of the Cox regression model, maternal education was found to be the only background factor with a significant effect on mortality. When background factors were controlled for, the mortality of children exposed to measles was significantly higher than that of controls in each of the age intervals 6-11, 12-23, and 24-35 months. For the large subgroup of children of mothers without any formal education, exposed children had 5.7 times (95% Cl 2.7-12.0) higher mortality than did the control children in the age interval 6-35 months. Diarrhea deaths were particularly common among exposed children. Of 22 children who had been exposed before age 6 months during a subsequent epidemic and had a blood test taken, there was a significantly higher mortality risk (27%) between 6 months and 5 years than in the 26 controls who had a blood test (0%). Children who had elevated antibody titers to measles after exposure had a particularly high mortality compared with controls. These results suggest that later childhood mortality may be related to infectious experiences during the first months of life. The possible long-term health consequences of exposure to measles virus should be considered when assessing the value of measles control programs.

Entities:  

Mesh:

Year:  1990        PMID: 2372002     DOI: 10.1093/oxfordjournals.aje.a115650

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  9 in total

1.  Identification of an immunodominant neutralizing and protective epitope from measles virus fusion protein by using human sera from acute infection.

Authors:  S F Atabani; O E Obeid; D Chargelegue; P Aaby; H Whittle; M W Steward
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Nutritional status and delayed mortality following early exposure to measles.

Authors:  P Aaby; M Andersen; K Knudsen
Journal:  Epidemiol Infect       Date:  1996-12       Impact factor: 2.451

3.  Measles control in Maputo, Mozambique, using a single dose of Schwarz vaccine at age 9 months.

Authors:  F T Cutts; O Monteiro; P Tabard; J Cliff
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

4.  Potential viral pathogenic mechanism for new variant inflammatory bowel disease.

Authors:  V Uhlmann; C M Martin; O Sheils; L Pilkington; I Silva; A Killalea; S B Murch; J Walker-Smith; M Thomson; A J Wakefield; J J O'Leary
Journal:  Mol Pathol       Date:  2002-04

5.  Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality.

Authors:  Michael J Mina; C Jessica E Metcalf; Rik L de Swart; A D M E Osterhaus; Bryan T Grenfell
Journal:  Science       Date:  2015-05-07       Impact factor: 47.728

6.  Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of age.

Authors:  P Aaby; M Andersen; M Sodemann; M Jakobsen; J Gomes; M Fernandes
Journal:  BMJ       Date:  1993-11-20

7.  Sex-specific differences in mortality after high-titre measles immunization in rural Senegal.

Authors:  P Aaby; B Samb; F Simondon; K Knudsen; A M Seck; J Bennett; L Markowitz; P Rhodes; H Whittle
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

8.  Early Measles Vaccination During an Outbreak in the Netherlands: Short-Term and Long-Term Decreases in Antibody Responses Among Children Vaccinated Before 12 Months of Age.

Authors:  Iris D Brinkman; Jelle de Wit; Gaby P Smits; Hinke I Ten Hulscher; Maria C Jongerius; Taymara C Abreu; Fiona R M van der Klis; Susan J M Hahné; Marion P G Koopmans; Nynke Y Rots; Debbie van Baarle; Robert S van Binnendijk
Journal:  J Infect Dis       Date:  2019-07-19       Impact factor: 5.226

9.  Measles vaccination in the presence or absence of maternal measles antibody: impact on child survival.

Authors:  Peter Aaby; Cesário L Martins; May-Lill Garly; Andreas Andersen; Ane B Fisker; Mogens H Claesson; Henrik Ravn; Amabelia Rodrigues; Hilton C Whittle; Christine S Benn
Journal:  Clin Infect Dis       Date:  2014-05-14       Impact factor: 9.079

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.